CNA<\/a>).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing.<\/p>\nThere are \u201ca lot of factors\u201d behind price increases in the prescription drug market, Dr. Jack Hoadley, a health policy analyst and researcher at Georgetown University, told CNA. Thus, it\u2019s hard to attribute the 400 percent rise in cost of the EpiPen to one particular cause, he said.<\/p>\n
However, if Mylan \u2013 the manufacturer of the EpiPen \u2013 was simply \u201ctaking advantage of a partial monopoly,\u201d he continued, than one \u201ccould raise the question\u201d about the ethics of the cost increases.<\/p>\n
The EpiPen is an injection device used on a patient whose allergic reaction has become a medical emergency. Some 3.6 million Americans were prescribed an EpiPen last year, according to the Wall Street Journal.<\/p>\n
In very serious cases, an allergic reaction can become Anaphylaxis, a life-threatening condition with symptoms including trouble breathing, reduced blood pressure, gastrointestinal problems, and itchy skin. Some of the most common reactions of Anaphylaxis are from peanut and shellfish allergies, bee stings, and latex exposure.<\/p>\n
These severe allergies require a hospital visit and an immediate injection of epinephrine, the drug in EpiPens.<\/p>\n
Since it acquired the EpiPen in 2007, Mylan has been raising the cost of the device. In 2007, two pens cost just over $100, but now they cost over $600, according to the New York Times. EpiPens can only be used once because of a spring-loaded mechanism for dispensing the epinephrine that activates upon injection.<\/p>\n
The news of the price hike has led to widespread outcry, with some critics citing Pope Francis, who has spoken out numerous times about the dangers of a free market when it is not governed by Christ-like principles and morals.<\/p>\n
Hoadley suggested that if the EpiPen price hike is an example of drug makers taking advantage of very limited competition, at the expense of people who need the drug, ethical questions could be raised.<\/p>\n
Different consumers will be affected by the cost hike in different ways, he noted.<\/p>\n
For instance, someone without insurance will have to pay the high out-of-pocket costs for the EpiPen. A low-income family whose children are on Medicaid or the Children\u2019s Health Insurance Program may obtain it for a small co-pay or even for free, and the cost would be passed on to the states or federal government.<\/p>\n
For those with private insurance, it would depend on their plan. In the short-term, there only might be a small increase in their co-pay, but a large increase in their premium later on.<\/p>\n
In cases where a health plan doesn\u2019t cover an EpiPen, however, patients may be on the hook for most or all of the cost of new pens.<\/p>\n
A number of reported upgrades were made to the device over the years, like a retractable needle and better grip for the pen. Many factors go into the cost of drugs, Hoadley explained, like the cost of ingredients, and producing and manufacturing a drug. Still, the cost of the epinephrine dosage in EpiPens has been estimated by experts to be only several dollars.<\/p>\n
But market forces can also play a big role in costs, he said, as when a drug company is devoid of real competition and there are no real \u201cmarket countervailing pressures\u201d for a drug company.<\/p>\n
In this particular case of EpiPens, he said, one competitor left the market over \u201cFDA issues.\u201d A competing pen, Auvi-Q is no longer available, and the FDA rejected another generic alternative to the EpiPen, according to the Times.<\/p>\n
A generic alternative still exists \u2013 Adrenaclick \u2013 for a lower cost, Consumer Reports has noted.<\/p>\n
Mylan has also pushed for its product to be in public schools as an emergency device. A federal law signed by President Obama in 2013 \u2013 which Mylan actively lobbied for \u2013 rewarded the states that mandated epinephrine injectors in schools. Mylan\u2019s program EpiPens4Schools provides several free pens per year for qualifying public schools.<\/p>\n
Mylan announced last week that it was taking measures to supposedly make it easier for patients to obtain EpiPens. They said they were \u201cdoubling eligibility for our patient assistance program,\u201d so that \u201ca family of four making up to $97,200 would pay nothing out of pocket for their EpiPen Auto-Injector.\u201d They also offered a \u201csavings card\u201d to trim costs by almost half for a two-pack of pens for those paying \u201cfull list price.\u201d<\/p>\n
\u201cWe recognize the significant burden on patients from continued, rising insurance premiums and being forced increasingly to pay the full list price for medicines at the pharmacy counter,\u201d Mylan CEO Heather Bresch said in a statement.<\/p>\n
Then on August 29, amid continuing outcry, the company announced that it would release a generic version of the product \u2013 containing the same drug and auto-injection function \u2013 for $300 per two-pack, half the price of the name brand version.<\/p>\n
It is unclear whether the announcement will be enough to satisfy critics.<\/p>\n
However, Hoadley said, Mylan\u2019s cost increase is a \u201csymptom of some of the issues that we\u2019re dealing with\u201d in the larger prescription drug market as a whole, where cost hikes of drugs have been linked by some to companies using \u201cmarket leverage.\u201d<\/p>\n
For instance, Martin Shkreli \u2013 former CEO of Turing Pharmaceuticals \u2013 made headlines after Turing increased the cost of its anti-parasite drug Daraprim from $13.50 to $750. Subpoenaed by Congress, he simply told members that he would \u201cinvoke my Fifth Amendment privilege against self-incrimination.\u201d<\/p>\n
\u00a0<\/p>\n
\u00a0<\/p>\n
\n
![](\"https:\/\/feeds.feedburner.com\/~ff\/catholicnewsagency\/dailynews?d=yIl2AUoC8zA\")
<\/a>\n<\/div>\n![\"\"](\"https:\/\/feeds.feedburner.com\/~r\/catholicnewsagency\/dailynews\/~4\/nEnfAYeqWzA\")
<\/p>\n<\/body><\/html>\n","protected":false},"excerpt":{"rendered":"
Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing.<\/p>\n
There are “a lot of factors” behind pr…<\/p>\n","protected":false},"author":1031,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-15722","post","type-post","status-publish","format-standard","hentry","category-us"],"yoast_head":"\n
As cost of EpiPen soars, what are the ethics of drug pricing?<\/title>\n<meta name=\"description\" content=\"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"As cost of EpiPen soars, what are the ethics of drug pricing?\" \/>\n<meta property=\"og:description\" content=\"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/\" \/>\n<meta property=\"og:site_name\" content=\"Catholic News\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-29T22:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.catholicnewsagency.com\/images\/size340\/Epi_Pen_Credit_Adam_Campbell_via_Flickr_CC_BY_ND_20_CNA.jpg\" \/>\n<meta name=\"author\" content=\"CNA Daily News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CNA Daily News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/\",\"url\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/\",\"name\":\"As cost of EpiPen soars, what are the ethics of drug pricing?\",\"isPartOf\":{\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/#website\"},\"datePublished\":\"2016-08-29T22:02:00+00:00\",\"dateModified\":\"2016-08-29T22:02:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/35d4bd7addc580050842c844a11575f1\"},\"description\":\"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"As cost of EpiPen soars, what are the ethics of drug pricing?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/#website\",\"url\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/\",\"name\":\"Catholic News\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/35d4bd7addc580050842c844a11575f1\",\"name\":\"CNA Daily News\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8f1180c7dca7995d4a997aac72a3a88a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8f1180c7dca7995d4a997aac72a3a88a?s=96&d=mm&r=g\",\"caption\":\"CNA Daily News\"},\"sameAs\":[\"http:\/\/www.catholicnewsagency.com\/\"],\"url\":\"https:\/\/www.patheos.com\/blogs\/catholicnews\/author\/cna-daily-news\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"As cost of EpiPen soars, what are the ethics of drug pricing?","description":"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/","og_locale":"en_US","og_type":"article","og_title":"As cost of EpiPen soars, what are the ethics of drug pricing?","og_description":"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...","og_url":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/","og_site_name":"Catholic News","article_published_time":"2016-08-29T22:02:00+00:00","og_image":[{"url":"http:\/\/www.catholicnewsagency.com\/images\/size340\/Epi_Pen_Credit_Adam_Campbell_via_Flickr_CC_BY_ND_20_CNA.jpg"}],"author":"CNA Daily News","twitter_card":"summary_large_image","twitter_misc":{"Written by":"CNA Daily News","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/","url":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/","name":"As cost of EpiPen soars, what are the ethics of drug pricing?","isPartOf":{"@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/#website"},"datePublished":"2016-08-29T22:02:00+00:00","dateModified":"2016-08-29T22:02:00+00:00","author":{"@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/35d4bd7addc580050842c844a11575f1"},"description":"Washington D.C., Aug 29, 2016 \/ 04:02 pm (CNA).- Amidst national outrage over the steep cost hike of a potentially life-saving drug, questions have been raised about the market ethics of drug pricing. There are “a lot of factors” behind pr...","breadcrumb":{"@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/2016\/08\/as-cost-of-epipen-soars-what-are-the-ethics-of-drug-pricing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.patheos.com\/blogs\/catholicnews\/"},{"@type":"ListItem","position":2,"name":"As cost of EpiPen soars, what are the ethics of drug pricing?"}]},{"@type":"WebSite","@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/#website","url":"https:\/\/www.patheos.com\/blogs\/catholicnews\/","name":"Catholic News","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.patheos.com\/blogs\/catholicnews\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/35d4bd7addc580050842c844a11575f1","name":"CNA Daily News","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.patheos.com\/blogs\/catholicnews\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8f1180c7dca7995d4a997aac72a3a88a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f1180c7dca7995d4a997aac72a3a88a?s=96&d=mm&r=g","caption":"CNA Daily News"},"sameAs":["http:\/\/www.catholicnewsagency.com\/"],"url":"https:\/\/www.patheos.com\/blogs\/catholicnews\/author\/cna-daily-news\/"}]}},"_links":{"self":[{"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/posts\/15722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/users\/1031"}],"replies":[{"embeddable":true,"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/comments?post=15722"}],"version-history":[{"count":0,"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/posts\/15722\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/media?parent=15722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/categories?post=15722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.patheos.com\/blogs\/catholicnews\/wp-json\/wp\/v2\/tags?post=15722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![](\"https:\/\/www.catholicnewsagency.com\/images\/size340\/Epi_Pen_Credit_Adam_Campbell_via_Flickr_CC_BY_ND_20_CNA.jpg\")
<\/p>\n